2 August 2017
DETAILS
Second Quarter 2017 Highlights
• Net Income of $161 million, up $179 million
with EPS of $0.84, up $0.94 per diluted share
• Adjusted Net Income of $166 million, up $117 million
with Adjusted EPS of $0.87, up $0.60 per diluted share
• Adjusted EBITDA of $361 million, up $174 million,
driven by strong year-over-year volume
and price improvement
in Titanium Technologies and Fluoroproducts
• Net leverage1 down to 2.2 times, well below target of 3 times
• Net Sales of $1.6 billion, up 15%
Mark Vergnano
Chemours President and CEO
“Our strong financial performance is a clear reflection of
* the quality of our business segments,
* the engagement of our employees and
* the loyalty of our key customers.
With two years behind us as a stand-alone company,
we are seeing the positive effects of our transformation plan
paired with improving end markets.
Customer preference for our Ti-Pure™ titanium dioxide
delivered another strong quarter
for our Titanium Technologies business.
Opteon™ refrigerants adoption ramp up remains in full force,
leading the double-digit volume growth reported
within Fluoroproducts.
Overall, these resulted in higher volumes
and significant margin improvement year-overyear.
We are pleased with the strength of the first half
and expect to continue this positive trajectory through 2017.”
VIEW CHEMOURS FULL PRESENTATION
CONTACT MEDIA
Alvenia Scarborough
Director, Brand Marketing and Corporate Communications
+1.302.773.4507
media@chemours.com
INVESTORS
Alisha Bellezza
Treasurer and Director of Investor Relations
+1.302.773.2263
investor@chemours.com
WWW.CHEMWINFO.COM BY KHUN PHICHAI
